Fu S[au] - Search Results

Year	Number of Results
1950	2
1951	2
1952	2
1953	2
1959	5
1962	2
1963	3
1964	4
1965	7
1966	2
1967	1
1969	1
1971	1
1972	1
1973	2
1974	8
1975	14
1976	3
1977	3
1978	10
1979	11
1980	13
1981	11
1982	6
1983	12
1984	14
1985	13
1986	11
1987	13
1988	24
1989	18
1990	10
1991	11
1992	17
1993	18
1994	29
1995	19
1996	20
1997	24
1998	23
1999	34
2000	34
2001	33
2002	43
2003	61
2004	60
2005	109
2006	94
2007	115
2008	185
2009	230
2010	187
2011	235
2012	270
2013	300
2014	378
2015	355
2016	387
2017	486
2018	528
2019	506
2020	584
2021	750
2022	929
2023	909
2024	1035
2025	1165
2026	809

1

The long shadow of a short life: How neutrophils confer trained immunity.

Liu F, Chai J, Yang P, Fu S, Li X, Jiang X, Li Y, Ji T, Fu Y, Hu H, Zhou J, Guo R, Li Y. Liu F, et al. Among authors: fu s. Autoimmun Rev. 2026 Aug 12;25(11):104164. doi: 10.1016/j.autrev.2026.104164. Online ahead of print. Autoimmun Rev. 2026. PMID: 42586179 Free article. Review.

2

The mineralocorticoid receptor and its antagonist finerenone regulate hepatic lipid accumulation via the AMPK/SREBP1/FASN signaling.

Fu S, Zhang M, Wang K, Huang S, Xi Y, Chen J, Xie D, Zhang Q, Que W, Ye X, Chen S, Liu Y, Wu M, Xu L, Ye C, Yamamoto T, Koyama H, Li C, Wu Y, Cheng J. Fu S, et al. Mol Cell Endocrinol. 2026 Oct;620:112845. doi: 10.1016/j.mce.2026.112845. Epub 2026 Jun 9. Mol Cell Endocrinol. 2026. PMID: 42264075

3

Single-cell transcriptomics uncovers endothelial progenitor-like remodelling driving human coronary atherosclerosis progression.

Yao F, Li F, Gai S, Chen Y, Liu F, Zhang X, Li J, Mao L, Guo L, Xing K, Huang J, Fu S, Sun Y, Chen J, Zhang H, Chen Y, Zhou B, Wang L, Zheng Z. Yao F, et al. Among authors: fu s. Nat Cell Biol. 2026 Aug;28(8):1671-1685. doi: 10.1038/s41556-026-02022-7. Epub 2026 Jul 14. Nat Cell Biol. 2026. PMID: 42448836

4

Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities.

Lin J, Chen C, Li S, Chen L, Fang M, Fu S, Chen K, Xu H, Zhang F, Wang R, Jiang C, Tang M, Liu Z, Wang S, Liu K, Niu C, Li B, Liu X, Cheng C, Tang AH, Qu K. Lin J, et al. Among authors: fu s. Nat Neurosci. 2026 Jun;29(6):1342-1354. doi: 10.1038/s41593-026-02265-5. Epub 2026 Apr 16. Nat Neurosci. 2026. PMID: 41992007

5

Mitochondrial metabolic reprogramming drives diabetic kidney disease progression: cell-specific mechanisms, metabolic memory, and targeted strategies.

Zhang L, Zhang Y, Han L, Wang J, Hou L, Fu S. Zhang L, et al. Among authors: fu s. Mol Med. 2026 Jun 10;32(1):128. doi: 10.1186/s10020-026-01521-5. Mol Med. 2026. PMID: 42271221 Free PMC article. Review.

6

Heterogeneity in the association between gut microbiota and insomnia moderated by Parkinson's disease status.

Lin SH, Lin RJ, Chang RY, Huang YF, Hsu YY, Chu CL, Chen YL, Lin CY, Fu SC. Lin SH, et al. Among authors: fu sc. Front Cell Infect Microbiol. 2026 May 5;16:1691665. doi: 10.3389/fcimb.2026.1691665. eCollection 2026. Front Cell Infect Microbiol. 2026. PMID: 42164266 Free PMC article.

7

Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway.

Xiao S, Wang M, Martin TG, Scott B, Fang X, Liu X, Yang Y, Fu S, Truong SD, Gugel JF, Maas GL, Mullen MP, Hill JH, Li VL, Markhard AL, Zhao M, Qi W, Reghupaty SC, Zhao M, Spaas J, Wei W, Moholdt T, Hawley JA, Voldstedlund CT, Richter EA, Chen X, Svensson KJ, Bernstein D, Leinwand LA, Xu Y, Long JZ. Xiao S, et al. Among authors: fu s. Nat Metab. 2026 Apr;8(4):869-884. doi: 10.1038/s42255-026-01485-0. Epub 2026 Mar 19. Nat Metab. 2026. PMID: 41857429 Free PMC article.

8

Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.

Peng Z, Liu T, Wang H, Wang J, Liu H, Ye F, Li E, Zhang J, Liu B, Lin R, Zhou A, Liu Z, Xu H, Wang Q, Niu Z, Yuan Y, Qin Y, Qu X, Bai Y, Liu N, Liu H, Bai C, Pan Y, Wang S, Wu T, Pan Q, Zhong D, Lu H, Wang J, Wang Z, Deng T, Gou H, Huang X, Fu S, Lu P, Yu J, Hong M, Xu Q, Wang L, Ren Y, Fan S, Shen L; Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma study group. Peng Z, et al. Among authors: fu s. Nat Med. 2026 Aug;32(8):2888-2897. doi: 10.1038/s41591-026-04459-7. Epub 2026 Jun 1. Nat Med. 2026. PMID: 42225990 Clinical Trial.

9

Ultralow-Dose Interleukin 10-Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nonrandomized Clinical Trial.

Hu Y, Zhang M, Gao M, Dong Y, Fu S, Li Y, Zhu X, Feng J, Hong R, Wei G, Zhao D, Cui J, Huang S, Yang T, Bai D, Cheng B, Cui Y, Ren J, Liu C, Li Y, Chen Q, Zhou Z, Wang D, Guo Y, Tang L, Wang X, Huang H. Hu Y, et al. Among authors: fu s. JAMA Oncol. 2026 Jul 23:e262490. doi: 10.1001/jamaoncol.2026.2490. Online ahead of print. JAMA Oncol. 2026. PMID: 42490071

10

Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection.

Yang Y, Pan Q, Liu M, Zeng L, Zou H, Liu S, Fu S, Xu Y, Dai Z, Fang S, Pan Y. Yang Y, et al. Among authors: fu s. Anal Chem. 2026 Jul 21;98(28):20968-20977. doi: 10.1021/acs.analchem.6c02601. Epub 2026 Jul 9. Anal Chem. 2026. PMID: 42424186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,109 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,109 results

Results by year